Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Study in Healthy Subjects to Investigate the Safety, Tolerability and Pharmacokinetics of Single Ascending and Repeat Doses of CT-1500

NCT05070702 is registered in ClinicalTrials.gov with Circadian Therapeutics Ltd as lead sponsor.

NCT NCT05070702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05070702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Study in Healthy Subjects to Investigate the Safety, Tolerability and Pharmacokinetics of Single Ascending and Repeat Doses of CT-1500
Lead sponsor
Circadian Therapeutics Ltd
Phase
Phase 1
Overall status
Completed
Start date
November 8, 2021
Completion date
July 7, 2022
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy